Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication
about
Nitric oxide inhibits HIV tat-induced NF-kB activationThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionBasal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism.HIV protein sequence hotspots for crosstalk with host hub proteins.Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha.NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site.Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR.Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cellsActivation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.IkappaB-mediated inhibition of virus-induced beta interferon transcription.Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression
P2860
Q23923154-41F0EFE3-FAED-4F50-AE18-D7EE57746315Q28386344-DAD95BFF-F244-43E1-81AA-E94828ED4E98Q30480091-0B48662E-676A-40C2-8620-1D4439886E38Q33649838-D5998628-71F6-431B-8403-EFF23D9353ADQ33902374-582C6DD3-2B2E-4DEA-AF8C-E085A9BAFC86Q33999393-C418D569-F3A5-4296-A6C3-AC8FCB0A5CFBQ35679713-24182005-65D8-43D7-8D00-1B003822851EQ35763310-8267FDFE-B96A-42EB-8C7A-827FB230D7F2Q35877650-CC6A5E8E-D53C-4FDC-8363-BEF369030642Q36097177-F85E929E-BB8B-412B-AE8F-4E5B89094236Q37114758-4479DEF4-3594-4B69-B752-95ADFCD924CFQ39459534-C9DB9924-0184-4E90-9449-D7DCC3527672Q39549729-670153D2-CE5E-4B63-88E7-2DB317F85184Q47555946-98E4F0D1-5AC0-4133-AA67-5F4D513BACC8Q58706821-56D6E2A7-1C48-4162-A4E1-A260B6CDF20F
P2860
Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Transdominant mutants of I kap ...... ssion and virus multiplication
@ast
Transdominant mutants of I kap ...... ssion and virus multiplication
@en
Transdominant mutants of I kap ...... ssion and virus multiplication
@nl
type
label
Transdominant mutants of I kap ...... ssion and virus multiplication
@ast
Transdominant mutants of I kap ...... ssion and virus multiplication
@en
Transdominant mutants of I kap ...... ssion and virus multiplication
@nl
prefLabel
Transdominant mutants of I kap ...... ssion and virus multiplication
@ast
Transdominant mutants of I kap ...... ssion and virus multiplication
@en
Transdominant mutants of I kap ...... ssion and virus multiplication
@nl
P2093
P2860
P1433
P1476
Transdominant mutants of I kap ...... ssion and virus multiplication
@en
P2093
M Wainberg
N Sonenberg
P Beauparlant
P2860
P304
P407
P577
1996-09-01T00:00:00Z